 |
cytochrome C, flavin mononucleotide and thiamin diphosphate |
|---|---|
| Trade Name | |
| Orphan Indication | Mitochondrial disorders |
| USA Market Approval | USA |
| USA Designation Date | 2011-06-17 00:00:00 |
| Sponsor | NBI Pharmaceuticals, Inc.;c/o Neil & Co CPAs, 1184 N. 15th Ave., Suite 1;Bozeman, Montana, 59715 |
